Drug Utilization Review
The primary objectives of Drug Utilization Review (DUR) are to improve the quality of health care for Medicaid members and to assist in containing health care costs. In order to achieve these goals, prescription claims must be reviewed both prospectively and retrospectively. Findings of the reviews are communicated to both prescribers and pharmacists to assure that medications provided are appropriate, medically necessary, and not likely to result in adverse medical effects. Drug Utilization Review is mandated by the Omnibus Budget Reconciliation Act of 1990 (OBRA ’90), an amendment to the Social Security Act.
Calendar, Agendas and Minutes
All meetings are held from 4-6 pm in the Lower Level Conference Room of the DHHR Building at 350 Capitol Street, Charleston, WV.
Brian M. Thompson, MS, PharmD
Drug Utilization Review Coordinator